STT3B-Dependent Posttranslational N-Glycosylation as a Surveillance System for Secretory Protein

Molecular Cell

Volumn 47, Issue 1, 2012, Pages 99-110

  Sato, Takashi ^a,b   Sako, Yasuhiro ^a   Sho, Misato ^a   Momohara, Mamiko ^a   Suico, Mary Ann ^a   Shuto, Tsuyoshi ^a   Nishitoh, Hideki ^c   Okiyoneda, Tsukasa ^d   Kokame, Koichi ^e   Kaneko, Masayuki ^f   Taura, Manabu ^a   Miyata, Masanori ^a   Chosa, Keisuke ^a   Koga, Tomoaki ^a   Morino Koga, Saori ^a   Wada, Ikuo ^b   Kai, Hirofumi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF MIYAZAKI   (Japan)

^d MCGILL UNIVERSITY   (Canada)

^e NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^f CHIBA INSTITUTE OF SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDES AND PROTEINS; PREALBUMIN; PROTEIN STT3B; SECRETORY PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; ENDOPLASMIC RETICULUM ASSOCIATED DEGRADATION; FAMILIAL AMYLOIDOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN HOMEOSTASIS; PROTEIN PROCESSING; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; AZETIDINECARBOXYLIC ACID; ENDOPLASMIC RETICULUM; GLYCOSYLATION; HEK293 CELLS; HEXOSYLTRANSFERASES; HUMANS; IMMUNOBLOTTING; MEMBRANE PROTEINS; MODELS, BIOLOGICAL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; POLYSACCHARIDES; PREALBUMIN; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; PROTEIN UNFOLDING; RNA INTERFERENCE; SECRETORY PATHWAY; SEQUENCE HOMOLOGY, AMINO ACID; UBIQUITIN-CONJUGATING ENZYMES; UBIQUITIN-PROTEIN LIGASES;

EID: 84863846134     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2012.04.015     Document Type: Article

References (42)

1. Balch W.E., Morimoto R.I., Dillin A., Kelly J.W. Adapting proteostasis for disease intervention. Science 2008, 319:916-919.
2. Bernasconi R., Galli C., Calanca V., Nakajima T., Molinari M. Stringent requirement for HRD1, SEL1L, and OS-9/XTP3-B for disposal of ERAD-LS substrates. J. Cell Biol. 2010, 188:223-235.
3. Bolt G., Kristensen C., Steenstrup T.D. Posttranslational N-glycosylation takes place during the normal processing of human coagulation factor VII. Glycobiology 2005, 15:541-547.
4. Cameron P.H., Chevet E., Pluquet O., Thomas D.Y., Bergeron J.J. Calnexin phosphorylation attenuates the release of partially misfolded alpha1-antitrypsin to the secretory pathway. J. Biol. Chem. 2009, 284:34570-34579.
5. Chen B., Mariano J., Tsai Y.C., Chan A.H., Cohen M., Weissman A.M. The activity of a human endoplasmic reticulum-associated degradation E3, gp78, requires its Cue domain, RING finger, and an E2-binding site. Proc. Natl. Acad. Sci. USA 2006, 103:341-346.
6. Chen M., Gutierrez G.J., Ronai Z.A. Ubiquitin-recognition protein Ufd1 couples the endoplasmic reticulum (ER) stress response to cell cycle control. Proc. Natl. Acad. Sci. USA 2011, 108:9119-9124.
7. Christianson J.C., Shaler T.A., Tyler R.E., Kopito R.R. OS-9 and GRP94 deliver mutant alpha1-antitrypsin to the Hrd1-SEL1L ubiquitin ligase complex for ERAD. Nat. Cell Biol. 2008, 10:272-282.
8. Culyba E.K., Price J.L., Hanson S.R., Dhar A., Wong C.H., Gruebele M., Powers E.T., Kelly J.W. Protein native-state stabilization by placing aromatic side chains in N-glycosylated reverse turns. Science 2011, 331:571-575.
9. Ellgaard L., Helenius A. Quality control in the endoplasmic reticulum. Nat. Rev. Mol. Cell Biol. 2003, 4:181-191.
10. Hamilton J.A., Benson M.D. Transthyretin: a review from a structural perspective. Cell. Mol. Life Sci. 2001, 58:1491-1521.
11. Hammarström P., Sekijima Y., White J.T., Wiseman R.L., Lim A., Costello C.E., Altland K., Garzuly F., Budka H., Kelly J.W. D18G transthyretin is monomeric, aggregation prone, and not detectable in plasma and cerebrospinal fluid: a prescription for central nervous system amyloidosis?. Biochemistry 2003, 42:6656-6663.
12. Hegde R.S., Ploegh H.L. Quality and quantity control at the endoplasmic reticulum. Curr. Opin. Cell Biol. 2010, 22:437-446.
13. Helenius A., Aebi M. Roles of N-linked glycans in the endoplasmic reticulum. Annu. Rev. Biochem. 2004, 73:1019-1049.
14. Hirao K., Natsuka Y., Tamura T., Wada I., Morito D., Natsuka S., Romero P., Sleno B., Tremblay L.O., Herscovics A., et al. EDEM3, a soluble EDEM homolog, enhances glycoprotein endoplasmic reticulum-associated degradation and mannose trimming. J. Biol. Chem. 2006, 281:9650-9658.
15. Jitsuhara Y., Toyoda T., Itai T., Yamaguchi H. Chaperone-like functions of high-mannose type and complex-type N-glycans and their molecular basis. J. Biochem. 2002, 132:803-811.
16. Kaneko M., Ishiguro M., Niinuma Y., Uesugi M., Nomura Y. Human HRD1 protects against ER stress-induced apoptosis through ER-associated degradation. FEBS Lett. 2002, 532:147-152.
17. Kikkert M., Doolman R., Dai M., Avner R., Hassink G., van Voorden S., Thanedar S., Roitelman J., Chau V., Wiertz E. Human HRD1 is an E3 ubiquitin ligase involved in degradation of proteins from the endoplasmic reticulum. J. Biol. Chem. 2004, 279:3525-3534.
18. Kitagawa K., Kotake Y., Kitagawa M. Ubiquitin-mediated control of oncogene and tumor suppressor gene products. Cancer Sci. 2009, 100:1374-1381.
19. Lenk U., Yu H., Walter J., Gelman M.S., Hartmann E., Kopito R.R., Sommer T. A role for mammalian Ubc6 homologues in ER-associated protein degradation. J. Cell Sci. 2002, 115:3007-3014.
20. Lilley B.N., Ploegh H.L. A membrane protein required for dislocation of misfolded proteins from the ER. Nature 2004, 429:834-840.
21. Liu Y., Choudhury P., Cabral C.M., Sifers R.N. Oligosaccharide modification in the early secretory pathway directs the selection of a misfolded glycoprotein for degradation by the proteasome. J. Biol. Chem. 1999, 274:5861-5867.
22. Marcus N.Y., Perlmutter D.H. Glucosidase and mannosidase inhibitors mediate increased secretion of mutant alpha1 antitrypsin Z. J. Biol. Chem. 2000, 275:1987-1992.
23. Molinari M., Calanca V., Galli C., Lucca P., Paganetti P. Role of EDEM in the release of misfolded glycoproteins from the calnexin cycle. Science 2003, 299:1397-1400.
24. Nakatsukasa K., Brodsky J.L. The recognition and retrotranslocation of misfolded proteins from the endoplasmic reticulum. Traffic 2008, 9:861-870.
25. Nakatsukasa K., Okada S., Umebayashi K., Fukuda R., Nishikawa S., Endo T. Roles of O-mannosylation of aberrant proteins in reduction of the load for endoplasmic reticulum chaperones in yeast. J. Biol. Chem. 2004, 279:49762-49772.
26. Oda Y., Hosokawa N., Wada I., Nagata K. EDEM as an acceptor of terminally misfolded glycoproteins released from calnexin. Science 2003, 299:1394-1397.
27. Oda Y., Okada T., Yoshida H., Kaufman R.J., Nagata K., Mori K. Derlin-2 and Derlin-3 are regulated by the mammalian unfolded protein response and are required for ER-associated degradation. J. Cell Biol. 2006, 172:383-393.
28. Okuda-Shimizu Y., Hendershot L.M. Characterization of an ERAD pathway for nonglycosylated BiP substrates, which require Herp. Mol. Cell 2007, 28:544-554.
29. Petrescu A.J., Milac A.L., Petrescu S.M., Dwek R.A., Wormald M.R. Statistical analysis of the protein environment of N-glycosylation sites: implications for occupancy, structure, and folding. Glycobiology 2004, 14:103-114.
30. Polyak K., Lee M.H., Erdjument-Bromage H., Koff A., Roberts J.M., Tempst P., Massagué J. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 1994, 78:59-66.
31. Ruiz-Canada C., Kelleher D.J., Gilmore R. Cotranslational and posttranslational N-glycosylation of polypeptides by distinct mammalian OST isoforms. Cell 2009, 136:272-283.
32. Sato T., Susuki S., Suico M.A., Miyata M., Ando Y., Mizuguchi M., Takeuchi M., Dobashi M., Shuto T., Kai H. Endoplasmic reticulum quality control regulates the fate of transthyretin variants in the cell. EMBO J. 2007, 26:2501-2512.
33. Sekijima Y., Wiseman R.L., Matteson J., Hammarström P., Miller S.R., Sawkar A.R., Balch W.E., Kelly J.W. The biological and chemical basis for tissue-selective amyloid disease. Cell 2005, 121:73-85.
34. Shen Y., Ballar P., Apostolou A., Doong H., Fang S. ER stress differentially regulates the stabilities of ERAD ubiquitin ligases and their substrates. Biochem. Biophys. Res. Commun. 2007, 352:919-924.
35. Sousa M.M., Saraiva M.J. Neurodegeneration in familial amyloid polyneuropathy: from pathology to molecular signaling. Prog. Neurobiol. 2003, 71:385-400.
36. Suico M.A., Yoshida H., Seki Y., Uchikawa T., Lu Z., Shuto T., Matsuzaki K., Nakao M., Li J.D., Kai H. Myeloid Elf-1-like factor, an ETS transcription factor, up-regulates lysozyme transcription in epithelial cells through interaction with promyelocytic leukemia protein. J. Biol. Chem. 2004, 279:19091-19098.
37. Susuki S., Sato T., Miyata M., Momohara M., Suico M.A., Shuto T., Ando Y., Kai H. The Endoplasmic Reticulum-associated Degradation of Transthyretin Variants Is Negatively Regulated by BiP in Mammalian Cells. J. Biol. Chem. 2009, 284:8312-8321.
38. Tiwari S., Weissman A.M. Endoplasmic reticulum (ER)-associated degradation of T cell receptor subunits. Involvement of ER-associated ubiquitin-conjugating enzymes (E2s). J. Biol. Chem. 2001, 276:16193-16200.
39. Vembar S.S., Brodsky J.L. One step at a time: endoplasmic reticulum-associated degradation. Nat. Rev. Mol. Cell Biol. 2008, 9:944-957.
40. Ye Y., Meyer H.H., Rapoport T.A. The AAA ATPase Cdc48/p97 and its partners transport proteins from the ER into the cytosol. Nature 2001, 414:652-656.
41. Ye Y., Shibata Y., Yun C., Ron D., Rapoport T.A. A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol. Nature 2004, 429:841-847.
42. Younger J.M., Chen L., Ren H.Y., Rosser M.F., Turnbull E.L., Fan C.Y., Patterson C., Cyr D.M. Sequential quality-control checkpoints triage misfolded cystic fibrosis transmembrane conductance regulator. Cell 2006, 126:571-582.